Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate
β Scribed by Y. Kuroda; M. Ito; K. Toshima; E. Takeda; E. Naito; T. J. Hwang; T. Hashimoto; M. Miyao; M. Masuda; K. Yamashita; T. Adachi; Y. Suzuki; K. Nishiyama
- Publisher
- Springer
- Year
- 1986
- Tongue
- English
- Weight
- 713 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sir: Dichloroacetate (DCA, 15-20 mg/kg per day) was given orally twice daily to a 12-mouth-old boy with congenital lactic acidosis [1,3]. The clinical and laboratory findings were compatible with Leigh syndrome [2]. Enzyme activities associated with lactate metabolism were normal in his fibroblasts
Entecavir is a potent nucleoside inhibitor of the hepatitis B virus (HBV) polymerase with a high antiviral efficacy and a high genetic barrier to viral resistance. After approval in 2006, knowledge on the side effect profile in patients with advanced liver disease and impaired liver function is stil
Passive immunization used for treatment of gastrointestinal infections represents a safe and effective method in premature and full-term newborns, avoiding the use of oral antibiotics.